Eupraxia Pharmaceuticals (X43.F) Q2 2025 Earnings

6MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-0.19
-0.17
-0.14
-0.12

Details

Expected EPS
-0.14804081198037
Actual EPS
-0.160077760885872
Surprise EPS
-0.01
Surprise Percent
+8.13%

Description

Eupraxia Pharmaceuticals (X43.F) has reported earnings of -0.160077760885872 per share for Q2 2025.

0 Comments

Share your thoughts